Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral Nervous System Diseases AND Breast Neoplasms”

247 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 247 results

Not applicableStudy completedNCT04659980
What this trial is testing

Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 62
Testing effectiveness (Phase 2)Looking for participantsNCT07109817
What this trial is testing

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

Who this might be right for
Breast CancerPeripheral Neuropathy
Montefiore Medical Center 116
Testing effectiveness (Phase 2)Ended earlyNCT01815346
What this trial is testing

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT06731894
What this trial is testing

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Who this might be right for
Breast CarcinomaChemotherapy-Induced Peripheral NeuropathyColon Carcinoma
City of Hope Medical Center 120
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Very early researchWithdrawnNCT05672342
What this trial is testing

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Who this might be right for
Breast CarcinomaChemotherapy-Induced Peripheral NeuropathyColon Carcinoma
City of Hope Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.
Large-scale testing (Phase 3)Study completedNCT00195013
What this trial is testing

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

Who this might be right for
Peripheral NeuropathyBreast Cancer
Weill Medical College of Cornell University 30
Not applicableEnded earlyNCT01881932
What this trial is testing

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

Who this might be right for
Breast CancerColorectal Cancer
University of Maryland, Baltimore 19
Not applicableUnknownNCT05099562
What this trial is testing

Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Affiliated Hospital of Qinghai University 54
Not applicableStudy completedNCT03272919
What this trial is testing

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Loma Linda University 44
Not applicableStudy completedNCT07475520
What this trial is testing

Lidocaine IV Injection With Different Doses for Patients With Neuropathic Pain After Mastectomy

Who this might be right for
Neuropathic Pain Induced by Mastectomy
Cairo University 30
Testing effectiveness (Phase 2)UnknownNCT05966441
What this trial is testing

Role of Curcumin in Paclitaxel Induced PN

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Ain Shams University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Ended earlyNCT02795572
What this trial is testing

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Who this might be right for
Peripheral Neuropathy in Breast Cancer Patient
AHS Cancer Control Alberta 13
Not applicableStudy completedNCT04480814
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

Who this might be right for
Breast Cancer
Pharmassist Ltd 30
Not applicableStudy completedNCT02129686
What this trial is testing

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

Who this might be right for
Taxane-induced Peripheral NeuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Early-Stage Breast Carcinoma+3 more
Dana-Farber Cancer Institute 57
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Load More Results